Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mylan's Matrix Unit Receives Final FDA Nod for Generic Version of Antiretroviral Zerit Capsules
Mylan's Matrix Unit Receives Final FDA Nod for Generic Version of Antiretroviral Zerit Capsules
Mylan's Matrix Unit Receives Final FDA Nod for Generic Version of Antiretroviral Zerit Capsules
Submitted by
admin
on December 30, 2008 - 9:39am
Source:
RTT News
News Tags:
Mylan
Stavudine
Headline:
Mylan's Matrix Unit Receives Final FDA Nod for Generic Version of Antiretroviral Zerit Capsules
Do Not Allow Advertisers to Use My Personal information
